Document Detail


Self-reported alcohol and drug use in pregnant young women: a pilot study of associated factors and identification.
MedLine Citation:
PMID:  21844837     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVES: This study describes the factors associated with self-reported substance use in pregnant young women attending a hospital clinic and evaluates 3 ways in its identification.
METHODS: A cross-sectional study of 30 pregnant young adults who responded to a mail survey containing the CRAFFT screening tool. All completed a diagnostic interview that included self-report information on their use of alcohol and drugs before and during pregnancy, the T-ACE screening tool, and the contexts in which they would be likely to use. Medical records were reviewed.
RESULTS: One-third of participants consumed alcohol, marijuana, or both while pregnant. Many had lifetime diagnoses of alcohol (23%) or cannabis (30%) use disorders, but only 1 met criteria for current diagnosis. Age, race, education, and children at home were not associated with either prenatal alcohol or cannabis use. Before pregnancy, alcohol drinking was associated with prenatal alcohol use (P = .02) and prenatal cannabis use (P = .06). Another trend of the before-pregnancy cannabis use being associated with prenatal cannabis use (P = .08) was observed. Most participants indicated little likelihood of substance use in convivial, intimate, or negative coping contexts while pregnant. However, participants with prenatal substance use had significantly higher convivial (P = .02) and intimate (P = .01) subscale scores of the Drinking Context Scale before pregnancy. Compared to the medical record and the T-ACE, the CRAFFT was best in identifying prenatal substance use (c-statistic = 0.9).
CONCLUSIONS: The CRAFFT screening instrument and asking about the contexts during which alcohol might have been consumed before pregnancy are promising approaches in the identification of prenatal substance use.
Authors:
Grace Chang; E John Orav; Jennifer A Jones; Tatyana Buynitsky; Stephanie Gonzalez; Louise Wilkins-Haug
Related Documents :
100517 - Ultrasonic planimetry of the gestation sac as a biometric method in early pregnancy.
11762537 - Reliability and validity of three-dimensional fetal brain volumes.
23285437 - Variations in the oral anaerobic microbial flora in relation to pregnancy.
22169397 - Passive fetal monitoring by adaptive wavelet denoising method.
2107537 - Umbilical cord haematoma as a complication of intrauterine intravascular blood transfus...
25364377 - Testing the developmental origins of health and disease hypothesis for psychopathology ...
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural    
Journal Detail:
Title:  Journal of addiction medicine     Volume:  5     ISSN:  1932-0620     ISO Abbreviation:  J Addict Med     Publication Date:  2011 Sep 
Date Detail:
Created Date:  2011-08-16     Completed Date:  2011-11-02     Revised Date:  2014-09-09    
Medline Journal Info:
Nlm Unique ID:  101306759     Medline TA:  J Addict Med     Country:  United States    
Other Details:
Languages:  eng     Pagination:  221-6     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Adult
Alcohol Drinking / epidemiology*
Alcoholism / epidemiology
Cannabis*
Cross-Sectional Studies
Female
Humans
Massachusetts / epidemiology
Pilot Projects
Pregnancy
Pregnancy Complications / epidemiology*
Pregnancy in Adolescence*
Prenatal Care
Questionnaires
Self Report*
Substance-Related Disorders / epidemiology*
Young Adult
Grant Support
ID/Acronym/Agency:
2K24AA00289/AA/NIAAA NIH HHS; K24 AA000289/AA/NIAAA NIH HHS; K24 AA000289-10/AA/NIAAA NIH HHS; M01 RR002635/RR/NCRR NIH HHS; M01 RR002635-225380/RR/NCRR NIH HHS; R01 AA014678/AA/NIAAA NIH HHS; R01 AA014678-04/AA/NIAAA NIH HHS; R01AA14678/AA/NIAAA NIH HHS
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Low risk for hepatitis C seroconversion in methadone maintenance treatment.
Next Document:  Bethanechol for buprenorphine-related urinary hesitancy: a case series.